Related Experiment Video
Updated: Sep 9, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Assessing subjective sleep reports in the first-degree relatives of antidepressant-treated depressed outpatients
Andrew G Mayers1, Johanna C Van Hooff, David S Baldwin
1University Department of Psychiatry, University of Southampton, UK. a.g.mayers@soton.ac.uk
Abstract:
This study sought to investigate whether first-degree relatives of depressed patients report, and react to, sleep perceptions in the same way as the depressed group. Our previous research suggested that depressed individuals may experience greater sleep 'distress' than healthy individuals; we wished to explore whether this was also apparent in their nearest relatives. A sample was recruited of 18 antidepressant-treated patients with a current DSM-IV diagnosis of major depressive disorder, 18 healthy controls, and a group of 10 first-degree relatives for each study group. In accordance with previous findings, poorer sleep perceptions corresponded with poorer life-quality and mood perceptions, and depressed individuals reported poorer sleep perceptions and poorer life-quality/mood perceptions than controls. Additionally, there was evidence of similar sleep reporting between depressed patients and their relatives, and for a difference between these relatives and other non-depressed groups. There was a non-significant trend for depressed patients, and their relatives, to report total sleep time in the same manner as each other, and differently to other non-depressed groups. Reports of poor sleep may be associated with reports of poor mood in depression, but in non-depressed individuals the association may be with a feeling of weariness.
Related Concept Videos
Blind Procedures
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
